Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The CardioGenomic Testing Alliance aims to increase the utilization of NGS panels for numerous cardiac conditions including arrhythmias and cardiomyopathies.
The researchers used mass spec and data analytics to develop lipid profiles that predicted diabetes and cardiovascular disease risk in the distant future.
SomaLogic Targeting Cardiovascular Risk Panel for Use as Surrogate Endpoint in Drug Development
Premium
In a study comprising more than 30,000 patients the panel provided strong discrimination between patients at lowest and highest risk for cardiovascular events.
International Heart Rhythm Societies Set Out Recommendations on Genetic Testing for Cardiac Diseases
The consensus statement, published this week, should help to guide decision-making around genetic testing for a variety of cardiac conditions.
Cardiology Genomic Testing Alliance Formed by Five Companies
The alliance comprises Illumina, Fulgent Genetics, Invitae, GeneDx, and PerkinElmer Genomics and aims to raise awareness and utilization of cardiogenomic testing.